ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis

Chen, Lixian; Zhou, Tianhao; White, Tori; O'Brien, April; Chakraborty, Sanjukta; Liangpunsakul, Suthat; Yang, Zhihong; Kennedy, Lindsey; Saxena, Romil; Wu, Chaodong; Meng, Fanyin; Huang, Qiaobing; Francis, Heather; Alpini, Gianfranco; Glaser, Shannon*南方医科大学
Hepatology2021-6DOI: 10.1002/hep.31545
21被引7阅读
引用收藏
分享

摘要

Background and Aims Apelin (APLN) is the endogenous ligand of its G protein-coupled receptor, apelin receptor (APJ). APLN serum levels are increased in human liver diseases. We evaluated whether the APLN-APJ axis regulates ductular reaction and liver fibrosis during cholestasis. @@@ Approach and Results We measured the expression of APLN and APJ and serum APLN levels in human primary sclerosing cholangitis (PSC) samples. Following bile duct ligation (BDL) or sham surgery, male wild-type (WT) mice were treated with ML221 (APJ antagonist) or saline for 1 week. WT and APLN(-/-) mice underwent BDL or sham surgery for 1 week. Multidrug resistance gene 2 knockout (Mdr2(-/-)) mice were treated with ML221 for 1 week. APLN levels were measured in serum and cholangiocyte supernatants, and cholangiocyte proliferation/senescence and liver inflammation, fibrosis, and angiogenesis were measured in liver tissues. The regulatory mechanisms of APLN-APJ in (1) biliary damage and liver fibrosis were examined in human intrahepatic biliary epithelial cells (HIBEpiCs) treated with APLN and (2) hepatic stellate cell (HSC) activation in APLN-treated human HSC lines (HHSteCs). APLN serum levels and biliary expression of APLN and APJ increased in PSC samples. APLN levels were higher in serum and cholangiocyte supernatants from BDL and Mdr2(-/-) mice. ML221 treatment or APLN(-/-) reduced BDL-induced and Mdr2(-/-)-induced cholangiocyte proliferation/senescence, liver inflammation, fibrosis, and angiogenesis. In vitro, APLN induced HIBEpiC proliferation, increased nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) expression, reactive oxygen species (ROS) generation, and extracellular signal-regulated kinase (ERK) phosphorylation. Pretreatment of HIBEpiCs with ML221, diphenyleneiodonium chloride (Nox4 inhibitor), N-acetyl-cysteine (NAC, ROS inhibitor), or PD98059 (ERK inhibitor) reduced APLN-induced cholangiocyte proliferation. Activation of HHSteCs was induced by APLN but reduced by NAC. @@@ Conclusions The APLN-APJ axis induces cholangiocyte proliferation through Nox4/ROS/ERK-dependent signaling and HSC activation through intracellular ROS. Modulation of the APLN-APJ axis may be important for managing cholangiopathies.

学科与关键词

关键词
HEPATIC STELLATE CELLSTHERAPEUTIC TARGETCELLULAR SENESCENCEAPJSYSTEMLIGANDINHIBITIONACTIVATIONAPOPTOSISPEPTIDES
相关
加载中…
  • cholangiocytes-specific deletion of sphingosine-1-phospholipid receptor 1 attenuate cholestasis induced liver injury and fibrosis
    Yuan Zihang; Wang, Jie; Miao, Yingying; Zhang, Haoran; Huang, Xinliang; Zhang, Luyong; Yu, Qw; Jiang, ZhenzhouInternational Liver Congress, London, ENGLAND, 2022-06-22 To 2022-06-26.
  • Glycocholic acid aggravates liver fibrosis by promoting the up-regulation of connective tissue growth factor in hepatocytes
    Yuan, Zihang; Wang, Jie; Zhang, Haoran; Chai, Yuanyuan; Xu, Yunxia; Miao, Yingying; Yuan, Ziqiao; Zhang, Luyong; Jiang, Zhenzhou*; Yu, Qinwei*Cellular Signalling, 2023, 101: 110508.被引 3
  • Obeticholic acid exacerbates the liver fibrosis of bile duct ligation model by inducing the liver expression of osteopontin
    Wang, Jie; Zihang, Yuan; Miao, Yingying; Zhang, Haoran; Wu, Qipeng; Huang, Xinliang; Zhang, Luyong; Yu, Q. W.; Jiang, ZhenzhouInternational Liver Congress, London, ENGLAND, 2022-06-22 To 2022-06-26.
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology
发表日期
2021-06
卷期
第 73 卷, 第 6 期
页码
2411-2428
DOI
10.1002/hep.31545
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
Hickam Endowed Chair, Gastroenterology from Indiana University; VA Research Senior Career Scientist Award; National Institutes of Health [DK054811, DK07698, DK107310, DK110035, DK062975, AA025997, AA025157, DK108959, DK119421, DK107682, AA025208, UH2AA026903, U01AA026917]; American Heart Association's Scientist Development Grant [17SDG33670306]; Indiana University Strategic Research Initiative; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative

作者

  • C

    Chen, Lixian (第一作者)

    2

  • Z

    Zhou, Tianhao

    2

查看全部 15 位作者收起作者
  • W

    White, Tori

    2

  • O

    O'Brien, April

    2

  • C

    Chakraborty, Sanjukta

    2

  • L

    Liangpunsakul, Suthat

  • Y

    Yang, Zhihong

  • K

    Kennedy, Lindsey

  • S

    Saxena, Romil

  • W

    Wu, Chaodong

  • M

    Meng, Fanyin

  • H

    Huang, Qiaobing

    southern med univ

  • F

    Francis, Heather

  • A

    Alpini, Gianfranco

  • G

    Glaser, Shannon (通讯)

    2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417